RAPP Company Profile and Key Details

NASDAQ : RAPP

Rapport Therapeutics Common Stock

$40.59

-1.16-2.78%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Rapport Therapeutics, Inc. Common Stock (RAPP) stock declined over -2.78%, trading at $40.59 on NASDAQ, down from the previous close of $41.75. The stock opened at $41.37, fluctuating between $39.71 and $41.59 in the recent session.

Stock Snapshot

41.75

Prev. Close

1.48B

Market Cap

39.71

Day Low

-15.61

P/E Ratio

-2.6

EPS (TTM)

N/A

Cash Flow per Share

41.37

Open

36.5M

Number of Shares

41.585

Day High

47.84%

Free Float in %

N/A

Book Value

357.21K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 13, 2026	41.12	42.66	39.62	40.59	364.52K
Jul 10, 2026	42.06	42.06	38.88	41.75	435.48K
Jul 09, 2026	42.33	43.63	41.03	42.05	312.13K
Jul 08, 2026	39.65	43.00	38.48	41.99	981.46K
Jul 07, 2026	39.16	42.86	38.50	39.72	861.88K
Jul 06, 2026	39.09	39.90	38.50	38.57	266.97K
Jul 02, 2026	39.35	40.74	38.80	38.97	254.37K
Jul 01, 2026	41.40	42.00	39.26	39.39	303.92K
Jun 30, 2026	40.40	43.76	40.00	41.67	556.05K
Jun 29, 2026	40.06	40.91	39.37	40.39	435.92K
Jun 26, 2026	39.05	41.26	38.33	40.06	1.62M
Jun 25, 2026	40.00	41.70	38.64	38.91	410.19K
Jun 24, 2026	39.52	41.86	39.50	40.00	657.54K
Jun 23, 2026	37.83	39.45	37.08	38.88	206.1K
Jun 22, 2026	37.57	39.03	37.31	38.19	255.38K
Jun 18, 2026	37.75	38.13	36.46	37.34	355.44K
Jun 17, 2026	38.74	39.01	36.59	36.87	273.47K
Jun 16, 2026	38.44	38.65	36.76	38.49	156.7K
Jun 15, 2026	38.94	39.98	37.40	38.26	315.79K
Jun 12, 2026	35.62	39.17	35.61	38.40	255.56K

Contact Details

Boston, MA

United States

https://www.rapportrx.com 161 794 50548

About Company

Rapport Therapeutics, Inc. functions as a clinical-phase biopharmaceutical enterprise, concentrating its efforts on discovering and developing innovative small-molecule therapeutics for individuals living with central nervous system (CNS) disorders. Its flagship product candidate, RAP-219, is an experimental small molecule precisely designed to inhibit TARPy8-containing AMPARs with exceptional potency (picomolar affinity). This promising compound aims to treat focal epilepsy and a range of other neurological conditions, including peripheral neuropathic pain and bipolar disorder. The company's pipeline further includes RAP-199, another molecule targeting TARPy8, which boasts distinct chemical and pharmacokinetic profiles. Moreover, Rapport is advancing several nicotinic acetylcholine receptor (nAChR) programs, such as an a6 nAChR therapy for chronic pain and an a9a10 nAChR treatment intended for hearing impairments. Formed in 2022 under the initial name Precision Neuroscience NewCo, Inc., the company adopted its current identity as Rapport Therapeutics, Inc. in October 2022, and its operations are based in Boston, Massachusetts.

Stock Peers

ARGX

-1.37-0.16%

argenx SE$876.25 REGN

-1.43-0.22%

Regeneron Pharmaceuticals, Inc.$663.09 UTHR

-11.49-2.10%

United Therapeutics Corporation$535.57 MDGL

-5.7-1.06%

Madrigal Pharmaceuticals, Inc.$531.00 VRTX

-5.14-1.06%

Vertex Pharmaceuticals Incorporated$480.25 KRYS

-2.37-0.65%

Krystal Biotech, Inc.$363.44 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

-10.43-3.21%

Praxis Precision Medicines, Inc.$314.56 LGND

-6.99-2.21%

Ligand Pharmaceuticals Incorporated$309.25 ONC

5.26001+1.76%

BeOne Medicines AG$303.96

Frequently Asked Questions

What is the current Rapport Therapeutics, Inc. Common Stock (RAPP) stock price?

Rapport Therapeutics, Inc. Common Stock (NASDAQ: RAPP) stock price is $40.59 in the last trading session. During the trading session, RAPP stock reached the peak price of $41.59 while $39.71 was the lowest point it dropped to. The percentage change in RAPP stock occurred in the recent session was -2.78% while the dollar amount for the price change in RAPP stock was - $1.16.

RAPP's industry and sector of operation?

The NASDAQ listed RAPP is part of Biotechnology industry that operates in the broader Healthcare sector. Rapport Therapeutics, Inc. Common Stock designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of RAPP?

No Data

How RAPP did perform over past 52-week?

RAPP's closing price is 202.23% higher than its 52-week low of $13.43 where as its distance from 52-week high of $43.76 is -7.24%.

How many employees does RAPP have?

Number of RAPP employees currently stands at 84.

Link for RAPP official website?

Official Website of RAPP is: https://www.rapportrx.com

How do I contact RAPP?

RAPP could be contacted at phone 161 794 50548 and can also be accessed through its website. RAPP operates from 1325 Boylston Street, Boston, MA , United States.

How many shares of RAPP are traded daily?

RAPP stock volume for the day was 357.21K shares. The average number of RAPP shares traded daily for last 3 months was 389.19K.

What is the market cap of RAPP currently?

The market value of RAPP currently stands at $1.48B with its latest stock price at $40.59 and 36.5M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	84
Beta	0.95
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

Employees	84
Beta	0.95
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

RAPP Company Profile and Key Details

Rapport Therapeutics Common Stock

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Dividend & Fair Value

Financial & Profitability Overview

Company Overview

Technical Performance

Shareholding & Insider Activity

Earnings & Analyst Outlook

Valuation Metrics

Price Forecast & Outlook

Key Takeaways